Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Sep;77(9):5409–5413. doi: 10.1073/pnas.77.9.5409

Syngeneic tumor cells can induce alloreactive T killer cells: a biological role for transplantation antigens.

V Schirrmacher, D Hübsch, F Garrido
PMCID: PMC350068  PMID: 6449011

Abstract

A chemically induced sarcoma of BALB/c (H-2d) mice, MCG4, is shown to induce in BALB/c lymphocytes a primary anti-tumor cytolytic T lymphocyte (CTL) reaction in vitro. The anti-tumor CTL showed tumor specificity but reacted also with normal cells expressing distinct H-2 alloantigens. The CTL response could be shown to be induced by and directed against alloantigenic determinants expressed on two different molecules, one H-2Kk-like the other H-2Dk-like. The biological significance of these findings is discussed with regard to (i) possibility of derepression of normally silent H-2 genes in tumor cells and normal cells, (ii) generation of alloreactivity in ontogeny, and (iii) role of alloreactive T cells in eliminating cells expressing wrong gH-2 antigens.

Full text

PDF
5409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodmer W. F. New genetic model for allelism at histocompatibility and other complex loci: polymorphism for control of gene expression. Transplant Proc. 1973 Dec;5(4):1471–1475. [PubMed] [Google Scholar]
  2. Bosslet K., Schirrmacher V., Shantz G. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro. Int J Cancer. 1979 Sep 15;24(3):303–313. doi: 10.1002/ijc.2910240306. [DOI] [PubMed] [Google Scholar]
  3. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  4. Finberg R., Burakoff S. J., Cantor H., Benacerraf B. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5145–5149. doi: 10.1073/pnas.75.10.5145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garrido F., Festenstein H., Schirrmacher V. Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Nature. 1976 Jun 24;261(5562):705–707. doi: 10.1038/261705a0. [DOI] [PubMed] [Google Scholar]
  6. Garrido F., Perez M., Torres M. D. Absence of four H-2d antigenic specificites in an H-2d sarcoma. J Immunogenet. 1979 Apr;6(2):83–86. doi: 10.1111/j.1744-313x.1979.tb00333.x. [DOI] [PubMed] [Google Scholar]
  7. Garrido F., Perez M., Torres M. D., Garcia-Olivares E., Ivanyi P., Schirrmacher V. A syngeneic anti tumor serum recognizing a complex H-2 alloantigen. Immunobiology. 1979 Aug;156(1-2):110–120. [PubMed] [Google Scholar]
  8. Garrido F., Schirrmacher V., Festenstein H. H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection. Nature. 1976 Jan 22;259(5540):228–230. doi: 10.1038/259228a0. [DOI] [PubMed] [Google Scholar]
  9. Gipson T. G., Imamura M., Conliffe M. A., Martin W. J. Lung tumor-associated derepressed alloantigen coded for by the K region of the H-2 major histocompatibility complex. J Exp Med. 1978 May 1;147(5):1363–1373. doi: 10.1084/jem.147.5.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jerne N. K. The somatic generation of immune recognition. Eur J Immunol. 1971 Jan;1(1):1–9. doi: 10.1002/eji.1830010102. [DOI] [PubMed] [Google Scholar]
  11. Lindahl K. F. Anomalous H-2 antigens on tumour cells. Nature. 1979 Jul 12;280(5718):105–106. doi: 10.1038/280105a0. [DOI] [PubMed] [Google Scholar]
  12. Martin W. J. Immune surveillance directed against depressed cellular and viral alloantigens. Cell Immunol. 1975 Jan;15(1):1–10. doi: 10.1016/0008-8749(75)90159-8. [DOI] [PubMed] [Google Scholar]
  13. Matzinger P., Bevan M. J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol. 1977 Mar 1;29(1):1–5. doi: 10.1016/0008-8749(77)90269-6. [DOI] [PubMed] [Google Scholar]
  14. Pellegrino M. A., Ferrone S., Brautbar C., Hayflick L. Changes in HL-A antigen profiles on SV40-transformed human fibroblasts. Exp Cell Res. 1976 Feb;97(2):340–345. doi: 10.1016/0014-4827(76)90625-x. [DOI] [PubMed] [Google Scholar]
  15. Roman J. M., Bonavida B. Expression of inappropriate H-2 antigens on SJL reticulum cell tumors. Transplant Proc. 1979 Jun;11(2):1365–1366. [PubMed] [Google Scholar]
  16. Schirrmacher V., Bosslet K., Shantz G., Clauer K., Hübsch D. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes. Int J Cancer. 1979 Feb;23(2):245–252. doi: 10.1002/ijc.2910230216. [DOI] [PubMed] [Google Scholar]
  17. Schirrmacher V., Garrido F., Garcia-Olivares F., Perez M., Torres M. D. Expression of foreign H-2-like antigens by a chemically-induced murine tumour (MCG4). J Immunogenet. 1980 Feb;7(1):51–59. doi: 10.1111/j.1744-313x.1980.tb00707.x. [DOI] [PubMed] [Google Scholar]
  18. Schirrmacher V., Garrido F., Hübsch D., Garcia-Olivares E., Koszinowski U. Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL. Transplant Proc. 1980 Mar;12(1):32–37. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES